Novartis Beats Osteoporosis Drug Injury Suit

Law360, Los Angeles (February 19, 2013, 1:11 PM EST) -- A California federal judge on Friday tossed a woman's claims stemming from multidistrict litigation that Novartis Pharmaceuticals Corp.'s osteoporosis drugs Aredia and Zometa destroyed her jaw, ruling that three expert witnesses hadn't shown the drugs were responsible for her bone damage.

U.S. District Judge Susan Illston granted Novartis' motion to strike the expert testimony of plaintiff Linda Messick's three doctors asserting the osteoporosis medications had caused Messick's jaw to deteriorate, saying they hadn't used reliable scientific methods to make a definitive diagnosis and that her claims...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

Messick et al v. Novartis Pharmaceuticals Corporation


Case Number

3:12-cv-00693

Court

California Northern

Nature of Suit

Personal Inj. Prod. Liability

Judge

Susan Illston

Date Filed

February 12, 2012

Law Firms

Companies

Government Agencies

Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.